amgen horizon
FTC: Amgen-Horizon Deal Would Cement Monopoly for Treatment of Two Diseases
Commission pauses major biopharma transaction involving drugs priced in the hundreds of thousands of dollars. As part of the Federal Trade Commission’s promised campaign to…